The Axonal Hypothesis and Magnetic Resonance Spectroscopy of MS

Waxman SG. Membranes, myelin, and the pathophysiology of multiple sclerosis . N Engl J Med 1982;306: 1529-1533 .

Arnold DL , Matthews PM , Francis GS , O'Connor J , Antel JP. Proton Magnetic Resonance Spectroscopic Imaging for Metabolic Characterization of Demyelinating Plaques . Ann Neuro1 1992;31: 235-241 .

De Stefano N , Matthews PM , Fu L , et al. Axonal Damage Correlates with Disability in Patients with Relapsing Remitting Multiple Sclerosis: Results of a Longitudinal MR Spectroscopy Study. [In Press] Brain 1998;

Redford EJ , Kapoor R , Smith KJ. Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible . Brain 1997; 120(Pt 12): 2149-2157 .

Waxman SG. Sodium channel blockade by antibodies: a new mechanism of neurological disease? [editorial; comment] . Ann Neurol 1995;37(4): 421-423 .

Rivera-Quinones CMD , Schmelzer JD , Hunter SF , Low PA , Rodriguez M. Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis . Nature Medicine 1998;4(2): 187-193 .

Waxman SG. Demyelinating diseases New- pathological insights, new therapeutic targets . N Engl J Med 1998;338: 323-325 .

Trapp BD , Peterson J , Ransohoff RM , Rudick R , Mork S , Lars B. Axonal transection in the lesions of multiple sclerosis . N Engl J Med 1998;338: 278-285 .

. Ferguson B , Matyszak MK , Esiri MM , Perry VH. Axonal damage in acute multiple sclerosis lesions . Brain 1997; 120(Pt 3): 393-399 .

The neuropathology of multiple sclerosis. 151-171 .

Fu L , Matthews PM , De Stefano N , Worsley KJ , Narayanan S , Francis GS , Antel JP , Wolfson C , Arnold DL. Imaging axonal damage of normal appearing white matter in multiple sclerosis . Brain 1998; 121: 103-113 .